These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Drug treatment of anxiety disorders].
    Author: Scholz H, Lhotka R.
    Journal: Wien Med Wochenschr; 1991; 141(22):526-30. PubMed ID: 1686949.
    Abstract:
    Current customary medication with anxiolytic potential has different main-points of impact and individual potentials of risk, which influence strategies of therapy in a limiting way. Benzodiazepines--which are very effective in various anxiety-disorders--can therefore only be applied under well controllable conditions within a limited period of time, in order to reduce the risks of dependency. Also administration of low-doses neuroleptica--which within these doses also show a high potential of anxiety-impact beside a high tolerance--must be limited to a period of two or three months to prevent late development of dyskinesias. Main indications for the application of antidepressive drugs are panic-conditions, cases of phobia and depressive anxiety. In the following a therapy-pattern for management of panic-conditions with Clomipramin will be gone into more detailed. Complementary anxiolytic characteristics of Buspiron and beta-blockers with their specific indication-fields will be brought up.
    [Abstract] [Full Text] [Related] [New Search]